Wellkang® LLC
  • Introduction

  • List of Official Steps:
    1. Log-in Procedures
    2. Division Acceptance Criteria
    3. Reviewer Assignment
    4. FDA Requests for
      Additional Information

    5. Administrative Review
    6. Decision Letter Issued
  • 510(k) Status Program

    February 11, 2002:

    The FDA requires that all non-US medical device manufacturers wishing to market their products in the United States must have a local representative in the US, i.e. the “US Agent”.

    Wellkang LLC is your reliable “US Agent” in dealing with FDA.




    Premarket notification (PMN) submissions [510(k)]s for medical devices are reviewed and processed by the Center for Devices and Radiological Health (CDRH) within the FDA. The Office of Device Evaluation (ODE) within CDRH is responsible for the processing and review of 510(k)s and providing a decision related to clearance to market medical devices in the U.S. Within ODE there are six divisions organized according to medical scientific disciplines. Each ODE division has a scientific staff that performs scientific reviews of 510(k)s and other research (IDE) and marketing applications (PMA). These individuals are commonly referred to as ODE reviewers. For the most part, it is their recommendation that determines whether a new device is substantially equivalent (SE) or not substantially equivalent (NSE). The following is a description of how 510(k)s are processed and reviewed by ODE and the 510(k) programs that affect this process.

    Click here to continue...

    | Home | Services | Our Clients | About Us | Online Shop | Contact Us | Partners & Links |

    Copyright© 2004 - 2006 Wellkang® LLC - Member of Wellkang® Group
    All Rights Reserved. Terms of Use, Copyright& Disclaimer.
    Some information at this site is obtained from websites & publications of FDA
    Last updated on
    Melbourne, Florida, USA